Mar 7 |
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript
|
Mar 7 |
Q4 2023 Xeris Biopharma Holdings Inc Earnings Call
|
Mar 6 |
Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript
|
Mar 6 |
Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates
|
Mar 6 |
Xeris Pharmaceuticals GAAP EPS of -$0.10 in-line, revenue of $44.39M beats by $0.84M
|
Mar 6 |
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
|
Mar 6 |
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
|
Mar 5 |
Xeris Pharmaceuticals Q4 2023 Earnings Preview
|
Mar 5 |
Why Xeris (XERS) Might Surprise This Earnings Season
|
Feb 28 |
Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
|